(Q40674285)

22 September 2017

Anti-C1q autoantibodies, novel tests, and clinical consequences (English)

1 reference

22 September 2017

1 reference

3

1 reference

22 September 2017

1

Michael Mahler

1 reference

22 September 2017

Rosanne A van Schaarenburg

series ordinal

2

1 reference

22 September 2017

14 May 2013

1 reference

22 September 2017

Frontiers in Immunology

1 reference

22 September 2017

4

1 reference

22 September 2017

117

1 reference

Anti-C1q antibodies and their association with complement components in Indian systemic lupus erythematosus patients

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Immune complex signatures of patients with active and inactive SLE revealed by multiplex protein binding analysis on antigen microarrays

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

The discovery and development of belimumab: the anti-BLyS-lupus connection

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Complement activation by (auto-) antibodies.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Autoantibodies against C1q in systemic lupus erythematosus are antigen-driven

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

New directions in the treatment of systemic lupus erythematosus

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Familial clustering of non-nuclear autoantibodies and C3 and C4 complement components in systemic lupus erythematosus

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Complement component c1q and anti-c1q antibodies in theory and in clinical practice.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Role of complement and complement regulators in the removal of apoptotic cells.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Autoantibodies in lupus nephritis patients requiring renal transplantation

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Anti-C1q antibodies in hepatitis C virus infection

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Antibodies against C1q in patients with systemic lupus erythematosus

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Complement components and their autoantibodies

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Autoantibodies to complement components.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

C1q autoantibodies in HIV infection: correlation to elevated levels of autoantibodies against 60-kDa heat-shock proteins

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

The classical complement pathway: activation and regulation of the first complement component.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Conformational changes in C1q after binding to immune complexes: detection of neoantigens with monoclonal antibodies

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

C1g precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

IgG and IgA autoantibodies to C1q in systemic and renal diseases

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Autoantibodies against complement C1q in acute post-streptococcal glomerulonephritis

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Autoantibodies against complement C1q correlate with the thyroid function in patients with autoimmune thyroid disease.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Rapid improvement of SLE-specific cutaneous lesions by C1q immunoadsorption.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

C1q: a multifunctional ligand for a new immunoadsorption treatment.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Autoantibodies to the collagenous region of C1q occur in three strains of lupus-prone mice

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

Negative Anti-C1q Antibody Titers May Influence Therapeutic Decisions and Reduce the Number of Renal Biopsies in Systemic Lupus Erythematosus

2 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653116

C4b-binding Protein and Factor H Compensate for the Loss of Membrane-bound Complement Inhibitors to Protect Apoptotic Cells against Excessive Complement Attack

2 December 2018

1 reference

12 December 2020

High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis

1 reference

12 December 2020

Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China

1 reference

12 December 2020

Autoantibodies to the collagen-like region of C1Q deposit in glomeruli via C1Q in immune deposits

1 reference

12 December 2020

Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritis

1 reference

12 December 2020

Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients

1 reference

12 December 2020

Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis

1 reference

12 December 2020

Successful treatment of patients with systemic lupus erythematosus by immunoadsorption with a C1q column: a pilot study

1 reference

12 December 2020

Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay

1 reference

12 December 2020

Levels of antibodies against C1q and 60 kDa family of heat shock proteins in the sera of patients with various autoimmune diseases

1 reference

12 December 2020

Characterization of C1q-binding IgG complexes in systemic lupus erythematosus

1 reference

12 December 2020

Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus

1 reference

12 December 2020

C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus

1 reference

12 December 2020

Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis

1 reference

12 December 2020

The three-dimensional conformation of M and A globulin molecules

1 reference

12 December 2020

Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis

1 reference

12 December 2020

Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases

1 reference

12 December 2020

Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus

1 reference

12 December 2020

Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of antimouse C1q antibodies

1 reference

12 December 2020

Correlation between serum anti-C1q antibody levels and renal pathological characteristics and prognostic significance of anti-C1q antibody in lupus nephritis

1 reference

12 December 2020

Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4

1 reference

12 December 2020

Anti-C1q antibodies, sCD40L, TWEAK and CD4/CD8 ratio in systemic lupus erythematosus and their relations to disease activity and renal involvement

1 reference

12 December 2020

The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus

1 reference

12 December 2020

Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus

1 reference

12 December 2020

The relationship between serum titers of autoantibodies to C1q and age in the general population and in patients with systemic lupus erythematosus

1 reference

12 December 2020

IgG autoantibodies to C1q do not detectably influence complement activation in vivo and in vitro in systemic lupus erythematosus

1 reference

12 December 2020

Anti-C1q Autoantibodies in Lupus Nephritis

1 reference

12 December 2020

Anti-C1q autoantibodies in murine lupus nephritis

1 reference

12 December 2020

High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients

1 reference

12 December 2020

Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients

1 reference

12 December 2020

Identifiers

DOI

10.3389/FIMMU.2013.00117

1 reference

22 September 2017

1 reference

22 September 2017

1 reference

PMCID

3653116